Calls for MU Stage 3 Delay Get Louder | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Calls for MU Stage 3 Delay Get Louder

September 18, 2015
by Rajiv Leventhal
| Reprints

The American Medical Association (AMA) has made no secret in its desire to push back rulemaking for Stage 3 of the meaningful use program. Now, it has the official support of 41 medical societies.

In letters delivered to U.S. Department of Health & Human Services (HHS) Secretary Sylvia M. Burwell and Office of Management and Budget (OMB) Director Shaun Donovan, AMA and the medical societies urged the administration to pause the final stages of the federal government’s meaningful use program in light of pivotal changes to Medicare. 

The physician organizations noted that the proposed Stage 3 regulation was developed prior to and without consideration of the changes enacted by the Medicare Access and Chip Reauthorization Act (MACRA). Given the vital role of the meaningful use program in the reformed payment systems introduced by MACRA, proceeding with the proposed Stage 3 rules threatens to impede the healthcare delivery innovations Congress sought to promote when it passed the law, the letter stated.

The letter reads, “To date, 80 percent of physicians are utilizing EHRs, but less than 10 percent of physicians have successfully participated in MU Stage 2. Furthermore, due to the inflexible MU regulations and certification requirements, vendors have created software products that are frequently unusable, administratively burdensome, and in many instances do not promote clinically relevant patient care.”

AMA President Steven J. Stack, M.D. added in a statement, “There is growing bipartisan recognition in Congress that the direction of the meaningful use program needs to be reassessed in light of usability and interoperability challenges with electronic health record systems. Poorly performing systems that do not facilitate the seamless exchange of data would severely undermine the ability of the health system to support the implementation of the payment reforms outlined in MACRA.”

The AMA believes that pausing Stage 3 at this time will provide the opportunity to evaluate the environment and work with the administration to implement the needed changes to the meaningful use program that are currently under consideration.“ The AMA wants the meaningful use program to succeed. Pausing to reassess Stage 3 rules will not stop or delay progress with EHRs,” said Dr. Stack. “On the contrary, we firmly believe a temporary period of reevaluation will help move the program forward and drive innovation and adoption.”

Similarly, in July, AMA backed legislation by Congresswoman Renee Ellmers (R-NC), who introduced H.R. 3309—the Further Flexibility in HIT Reporting and Advancing Interoperability Act (or Flex-IT 2 Act)—which proposed, among other things, to delay Stage 3 rulemaking until at least 2017, or until Merit-based Incentive Payment System (MIPS) final rules, or until at least 75 percent of doctors and hospitals are successful in meeting Stage 2 requirements. As such, in the new letters to HHS an OMB, AMA also urged the feds to proceed with finalizing the Stage 2 Modifications Rule as well as with integral pieces of the proposed 2015 Edition Certification Rule as soon as possible. Earlier this month, the Centers for Medicare & Medicaid Services (CMS) sent the final rules for both meaningful use Stage 3 and Stage 2 modifications to OMB for review.

Perhaps starting the Stage 3 delay momentum, just this week, during a Senate hearing, Sen. Lamar Alexander (R-TN), Chairman of the Senate Health Education Labor and Pensions (HELP) Committee, once again pushed for a delay himself, citing the need to push back the making of a final rule until Jan. 1, 2017 due to physicians telling him they are “terrified” of the impending stage of the program. Not surprisingly, AMA backed those sentiments as well. Nonetheless, most indications are that the final rules for both Stage 2 modifications and Stage 3 will be signed by OMB and published in early fall.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Analysis: Healthcare Ransomware Attacks Decline in First Half of 2018

In the first half of 2018, ransomware events in major healthcare data breaches diminished substantially compared to the same time period last year, as cyber attackers move on to more profitable activities, such as cryptojacking, according to a new report form cybersecurity firm Cryptonite.

Dignity Health, UCSF Health Partner to Improve the Digital Patient Experience

Dignity Health and UCSF Health are collaborating to develop a digital engagement platform that officials believe will provide information and access to patients when and where they need it as they navigate primary and preventive care, as well as more acute or specialty care.

Report: Digital Health VC Funding Surges to Record $4.9 Billion in 2018

Global venture capital funding for digital health companies in the first half of 2018 was 22 percent higher year-over-year (YoY) with a record $4.9 billion raised in 383 deals compared to the $4 billion in 359 deals in the same time period last year, according to Mercom Capital Group’s latest report.

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.